Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bactiguard appoints new CEO

The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard immediately and take up the role of CEO on 1 October.“I am pleased to welcome Anders Göransson to lead Bactiguard into the future. I am convinced that Anders, with his solid international experience in pharmaceuticals and healthcare, combined with McKinsey's background, will take Bactiguard to new

EQT AB Completion of Partners’ sale of shares in EQT AB

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.As announced earlier today, EQT AB (“EQT”) has decided to prolong the EQT AB Partners’ (the “Partners”) IPO share lock-up period, alongside a partial lock-up release, as part of its next steps for future-proofing the firm and strengthening its long-term ownership framework. Pursuant to the lock-up revision, the Partners launched an accelerated book-building

BERGENBIO COMPLETES RECRUITMENT OF PHASE II AML STUDY (BGBC003)

Bergen, Norway, 7 September 2021 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, is pleased to announce the completion of patient recruitment into BGBC003 (ClinicalTrials.gov ID: NCT02488408), a Phase Ib/II multicenter open-label study of bemcentinib as a single agent and in combination with cytarabine or decitabine in patients with Acute Myeloid Leukemia (AML) or as a single agent in patients with myelodysplastic syndrome (MDS). BerGenBio has recruited a total of 86 patients in

EQT AB announces share lock-up revision to strengthen long-term alignment - share sale launched by Partners

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.EQT AB today announces it has prolonged the EQT AB Partners’ IPO share lock-up period, alongside a partial lock-up release, as part of its next steps for future-proofing the firm and strengthening its long-term ownership framework. Given the outperformance since EQT’s IPO in 2019, including strong investment performance and larger fundraisings, this proactive

Hexagon revolutionises autonomous reality capture with the launch of the Leica BLK ARC and Leica BLK2FLY

Hexagon AB, a global leader in digital reality solutions, today announced  the introduction of the Leica BLK ARC and the Leica BLK2FLY, extending its iconic and award-winning BLK series known for speed, portability and mobility with fully autonomous mobile reality capture. The autonomous reality capture solutions are the latest innovations in Hexagon’s comprehensive portfolio of accessible, easy-to-use digital reality capture sensors. The Leica BLK ARC is a laser scanning sensor purposely built to improve the autonomous navigation of robots and other carrier

Bulletin from the extraordinary general meeting in Zutec Holding AB (publ) on 7 September 2021

The extraordinary general meeting in Zutec Holding AB (publ) was held on Tuesday 7 September 2021. Due to the extraordinary situation because of the COVID-19 pandemic, the extraordinary general meeting was carried out through postal voting only, without any physical attendance. The general meeting resolved, with the required majority, on the resolutions below: Name change to BuildData Group AB It was resolved in accordance with the Board of Directors’ proposal to change the name of the Company to BuildData Group AB, and thus resolved to amendment to the Articles of Association.

#21-296 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-295 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 07.09.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 07.09.2021 at 18:30 EEST ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 07.09.2021 Date 07.09.2021Exchange transaction BuyShare class ALEXAmount 1,099Average price/share 8.8327 EURHighest price/share 8.8400 EURLowest price/share 8.8000 EURTotal price 9,707.14 EUR The shares held by Alexandria Pankkiiriliike Oyj on 07.09.2021: ALEX 13,276   On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (

Veidekke ASA: New residential contract at Løren in Oslo

Veidekke has been commissioned by OBOS Nye Hjem AS and Nordr AS to continue construction work as part of the Løren Botaniske residential project in Oslo. The commission encompasses the construction of two blocks of apartments housing 91 residential units in total, an underground car park and outdoor works as part of a design and build contract worth approximately NOK 235 million excluding VAT. The project aims to be environmentally certified in accordance with the BREEAM NOR Good standard.This is a new order relating to the already-commenced Løren Botaniske residential project. The two

Brighter is notified that its distributors in Nigeria and Ghana wish to renegotiate the distribution agreements - estimated revenues will either be substantially reduced or not materialise.

Brighter AB (Publ), the “Company” or “Brighter”), today announced that it has received notice from the company’s distribution partners Wssonlines Nigeria Ltd in Nigeria and Fretac Plus Ventures in Ghana (“the Distributors”) that they wish to renegotiate the distribution contracts in Nigeria and Ghana covering Actiste® and Actiste® Mini (“Actiste® Service”), which was originally announced on 30 December 2020. It is now anticipated by the Company that the estimated revenues from such distribution agreements (stated below) will either not materialise or will be substantially reduced.

ABS and Vanderbilt University Deliver Landmark US Waterways Decarbonization Report

Future Fuels, Decarbonization Technologies and Potential for Electrification Explored(HOUSTON) ABS and Vanderbilt University have published a landmark report analyzing decarbonization strategies for U.S. inland waterways. Decarbonization of the Inland Waterway Sector in the United States evaluates the potential for possible future propulsion technologies and alternative fuels to reduce carbon emissions. The report also demonstrates the feasibility of near-term electrification of smaller vessels operating on the inland river system with a case study and renderings of a weighted and

Volati extends credit agreement with Nordea

Volati has extended its existing credit agreement with Nordea by SEK 1,000 million. The agreement, which amounts to SEK 2,200 million after the increase, secures financing for Volati’s continued growth and acquisition-oriented work.  Volati is currently characterised by two fast-growing business areas and a strong focus on acquisitions. Average annual EBITA growth has been over 40 percent since 2017. In the last twelve months, Volati has made seven add-on acquisitions for existing companies and one acquisition that broadens operations to a new area – telecom infrastructure. The

Saab to deliver combat training solutions to Poland

Saab has signed a contract for the delivery of several live training systems and services to the Polish Armed Forces. The total order value is approximately 1 billion SEK and comprises the supply of a complete live training solution for a reinforced mechanised battalion and four training centres for company size units. The contract period is 2021 to 2026 including support over a period of three years. This order will ensure that the Polish Armed Forces are equipped with innovative, flexible training solutions and the required training capability. This will enable the customer to

Following CE Mark approval, Quantum Surgical announces the commercial launch of Epione® its medical robot dedicated to liver cancer

[Epione® the medical robot dedicated to liver cancer] Montpellier, France, September 7, 2021 - Quantum Surgical, an innovative medical robotics company, announces that it has recently obtained CE mark approval for Epi-one®, its robot designed for minimally invasive treatment of abdominal tumors. This authorization allows the commercial launch of Epione® on the European market. Epione® is a robotic solution developed to help physicians perform safer and more ef-fective percutaneous ablations in the abdomen, a minimally invasive treatment in which a needle is inserted through the skin

Neste to acquire US based Agri Trading to strengthen its renewable raw material trading and sourcing to serve increasing customer demand for renewable and circular solutions

Neste Corporation, Press Release, 7 September 2021 at 5.05 pm (EET)   Neste has agreed to acquire 100% of Agri Trading, one of the largest independent renewable waste and residue fat and oil traders in the United States, and its affiliate entities.The transaction is subject to the completion of customary closing conditions and regulatory approval. “This agreement supports our renewables growth strategy and further strengthens our global renewable raw material sourcing as well as our footprint in the United States. Agri Trading complements our previous acquisition of

Para-Athletes Using Össur Technology Dominate in Tokyo

Össur Athletes Win 28 Medals on "Gold Standard" Prosthetics Including the Iconic Cheetah BladeA global team of para-athletes who wear Össur’s renowned prosthetics won 28 medals and set new World and Paralympic Records during the recent 2020 Tokyo Paralympic Games, the company announced today.  Competitors using the company’s iconic carbon fiber Cheetah sports blades, easily identified by their yellow stripe, dominated several categories of competition, particularly Athletics.Athletes wearing Össur technologies competed in numerous events including Long Jump, Sprinting, Discus Throw,

SGL International A/S announces successful placement of subsequent bonds under its outstanding senior secured bond framework

SGL International A/S (the "Issuer", and together with TransGroup Global Inc., and their respective subsidiaries from time to time, “SGL” or the “Group”) has, following a bookbuilding process, successfully placed a subsequent bond issue (the “Subsequent Bond Issue”) in an amount of EUR 75,000,000 under its existing senior secured fixed rate bonds with ISIN SE0015810759 (the “Fixed Rate Bonds”). Following the Subsequent Bond Issue, the outstanding amount under the Fixed Rate Bonds will be EUR 225,000,000. The transaction was met with strong demand from primarily institutional investors based

Publication of a Prospectus

Regulatory Announcement     Royal Bank of Canada September 7, 2021   Publication of Prospectus   Not for release, publication or distribution, directly or indirectly, in or into the United States.   Royal Bank of Canada has agreed to issue GBP300,000,000 1.000 per cent. Senior Notes due September 9, 2026, Series 62788 (the "Notes") pursuant to its Programme for the Issuance of Securities (the "Programme").   The following document constitutes the final terms dated September 7, 2021 (the "Final Terms") relating to the admission to trading of the Notes for

Planmeca Oy announces intended acquisition of KaVo Treatment Unit & Instrument business

Planmeca Oy, one of the largest privately held manufacturers in the dental field, has entered into a binding contract to acquire the KaVo Treatment Unit & Instrument business from Envista Holdings Corporation. The acquisition will strengthen Planmeca’s and KaVo’s positions as leading providers of innovative dental solutions and increase Planmeca Group’s annual revenue to more than EUR 1,1 billion.The acquisition will complement Planmeca’s extensive product portfolio and enhance the growth and competitiveness of both companies, allowing them to offer the best possible modern digital workflow

Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland

Oslo, 7 September 2021 – Navamedic ASA (OSE: NAVA) receives approval for conditional reimbursement for Mysimba® in Finland from 1 November 2021. The company expects accelerated growth of Mysimba® in the Finnish market following the reimbursement, further fueled by Navamedic’s successful patient support program planned for launch in Finland in 2022.Mysimba® is the first obesity treatment of its kind, combining both an oral medicin with a digital and custom-made patient support program to maximise patients’ success in treatment. Mysimba® reduces hunger and cravings, and provides control over

Realheart’s CEO speaking at the ESAO Congress on September 10

On 10 September, Realheart's CEO Ina Laura Perkins will appear at the European Society for Artificial Organs' annual congress. She will give two separate lectures, one on blood research and one on Realheart's process of developing the world's first artificial four-chamber heart.ESAO 2021 will take place digitally from London on September 7-11. Participants will have the opportunity to present their latest research findings and engage in discussions with clinicians, scientists and engineers from both the public and private sectors on the development of lasting artificial organs. Ina Laura

There are no items matching the current filter
There are no more items matching the current filter
Back to top